发明名称 POLYCISTRONIC EXPRESSION OF ANTIBODIES IN CHO CELLS
摘要 Described herein is a eukaryotic cell that is stably transfected with a polycistronic vector for expressing functional antibodies, the vector comprises a polycistronic transcription system comprising the following elements operably linked in the 5' to 3' orientation: (i) a promoter operable in a eukaryotic cell; (ii) a first cistron comprising a first DNA sequence comprising a 5' start codon, a nucleotide sequence encoding an antibody light chain, and a 3' terminal stop codon, wherein said first DNA sequence does not comprise a poly A sequence at its 3' end; (iii) an internal ribosome entry site (IRES) obtained from a member selected from the group consisting of a cardiovirus, a herpes virus and a poliovirus; (iv) at least an additional cistron comprising a second DNA sequence comprising a 5' start codon, a nucleotide sequence encoding an antibody heavy chain, and a 3' terminal stop codon, wherein said second DNA sequence comprises a poly A sequence at its 3' terminus; wherein the IRES is operably linked to the 5' end of the additional cistron with no intervening regulatory elements; and wherein the functional antibodies expressed by the polycistronic vector specifically bind to a tumor associated antigen. Further described is a method of producing functional antibodies comprising culturing the eukaryotic cell of the invention in a cell culture to produce functional antibodies.
申请公布号 EP1456386(A2) 申请公布日期 2004.09.15
申请号 EP20020802572 申请日期 2002.11.18
申请人 IDEC PHARMACEUTICALS CORPORATION 发明人 REFF, MITCHELL;BARNETT, RICHARD
分类号 C12N15/09;A61K47/48;A61K51/10;A61P35/00;C07K16/00;C07K16/28;C07K16/30;C12N1/19;C12N5/10;C12N15/12;C12N15/85;C12P21/02;(IPC1-7):C12N15/63;C12N15/86;C12N15/00 主分类号 C12N15/09
代理机构 代理人
主权项
地址